Clinical assessment of sympathetic responses to stress.
Goldstein
D S
DS
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004837:Epinephrine / Q000378:metabolism*; D005089:Exocytosis; D006339:Heart Rate; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism* / Q000493:pharmacokinetics; D009647:Normetanephrine / Q000378:metabolism; D013312:Stress, Physiological / Q000175:diagnosis*; D013564:Sympathetic Nervous System / Q000378:metabolism*
D009647:Normetanephrine; D015102:3,4-Dihydroxyphenylacetic Acid; D008734:Methoxyhydroxyphenylglycol; D004295:Dihydroxyphenylalanine; C010117:3,4-dihydroxyphenylglycol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine